Based on these findings and prior to the retraction, Kotlabova and colleagues investigated the reliability of these five HSA-21 derived miRNAs and although HSA-MIR-155 was also found to be differentially expressed, they reported that miRNAs do not represent suitable biomarkers for the NIPD of DS [26]. Here, ALB is linked to Dravet syndrome.